Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study (2022)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1186/s42358-022-00276-x
- Subjects: MIOSITE; MANIFESTAÇÕES CUTÂNEAS; ANTICORPOS; ESTUDOS LONGITUDINAIS; BRASILEIROS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Advances in rheumatology
- ISSN: 2523-3106
- Volume/Número/Paginação/Ano: v. 62, n. 1, article ID 41, 9p, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
TRUZZI, Natassia Cristina Carboni et al. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study. Advances in rheumatology, v. 62, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s42358-022-00276-x. Acesso em: 17 fev. 2026. -
APA
Truzzi, N. C. C., Hoff, L. S., Borges, I. B. P., Souza, F. H. C. de, & Shinjo, S. K. (2022). Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study. Advances in rheumatology, 62( 1). doi:10.1186/s42358-022-00276-x -
NLM
Truzzi NCC, Hoff LS, Borges IBP, Souza FHC de, Shinjo SK. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2026 fev. 17 ] Available from: https://doi.org/10.1186/s42358-022-00276-x -
Vancouver
Truzzi NCC, Hoff LS, Borges IBP, Souza FHC de, Shinjo SK. Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study [Internet]. Advances in rheumatology. 2022 ; 62( 1):[citado 2026 fev. 17 ] Available from: https://doi.org/10.1186/s42358-022-00276-x - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
- COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
Informações sobre o DOI: 10.1186/s42358-022-00276-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
